Agilent Technologies Aktie
128,58USD | 2,90USD | 2,31% |
WKN: 929138 / ISIN: US00846U1016
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,60 |
The Vanguard Group, Inc. | 11,64 |
Vanguard Group, Inc. (Subfiler) | 11,19 |
Massachusetts Financial Services Co. | 5,43 |
Massachusetts Financial Services Co. | 5,43 |
State Street Corp. | 4,46 |
Vanguard Total Stock Market ETF | 3,21 |
BlackRock Fund Advisors | 3,17 |
Wellington Management Co. LLP (Wellington Breakout) | 2,90 |
T. Rowe Price Investment Management, Inc. | 2,87 |
Vanguard 500 Index Fund | 2,66 |
Geode Capital Management LLC | 2,42 |
Pictet Asset Management SA | 2,31 |
BlackRock Institutional Trust Co. NA | 2,25 |
Vanguard Mid Cap Index Fund | 2,15 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 16 300 | 16 400 | 17 000 | 18 100 | 18 100 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,32 | 0,33 | 0,37 | 0,38 | 0,38 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 3 189 | 3 415 | 3 799 | 3 778 | 4 186 |
Summe Anlagevermögen | 6 263 | 6 212 | 6 906 | 6 754 | 6 577 |
Summe Aktiva | 9 452 | 9 627 | 10 705 | 10 532 | 10 763 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 2 407 | 2 537 | 2 911 | 2 921 | 2 899 |
Summe Fremdkapital | 4 704 | 4 754 | 5 316 | 5 227 | 4 918 |
Summe Eigenkapital | 4 748 | 4 873 | 5 389 | 5 305 | 5 845 |
Summe Passiva | 9 452 | 9 627 | 10 705 | 10 532 | 10 763 |
Adresse
5301 Stevens Creek Boulevard, 95051 Santa Clara | |
Telefon | +1 (408) 553-2424 |
Internet | http://www.agilent.com |
Management
Angelica Riemann
President-Agilent CrossLab Group |
Boon Hwee Koh
Non-Executive Chairman |
Bret Morgan DiMarco
Secretary, Chief Legal Officer & Senior VP |
Daniel K. Podolsky
Independent Director |
Dow R. Wilson
Independent Director |
George A. Scangos
Independent Director |
Guillermo Gualino
Treasurer & Vice President |
Heidi Kunz Fields
Independent Director |
Henrik Ancher-Jensen
SVP & President-Order Fulfillment & Supply Chain |
Jenipher E. Dalton
Senior VP, Chief Quality & Regulatory Officer |
John Kohl
Chief Information Officer & Senior Vice President |
Jonah Kirkwood
Chief Commercial Officer |
Mala Anand
Independent Director |
Mikael Dolsten
Independent Director |
Otis W. Brawley
Independent Director |
P. Diana Chiu
Vice President & Assistant Secretary |
Padraig Mcdonnell
President, Chief Executive Officer & Director |
Parmeet Ahuja
Vice President-Investor Relations |
Robert W. McMahon
Chief Financial Officer & Senior Vice President |
Rodney Gonsalves
Chief Accounting Officer, VP & Controller |
Simon May
President-Diagnostics & Genomics Group |
Sue H. Rataj
Independent Director |